

MeVis BreastCare GmbH & Co. KG
MeVis BreastCare: Innovation for breast cancer diagnostics. As a leading provider, MeVis develops software solutions for image-based medicine to help clinicians with the early detection and treatment of breast cancer. Become part of our team!
MeVis BreastCare GmbH & Co. KG: Pioneer in Imaging for Breast Cancer Diagnostics
editMeVis BreastCare is a leading provider of innovative software solutions for image-based medicine, particularly in the areas of breast and liver cancer. Since its founding in 2001, the company has supported clinicians in the interpretation of multimodal images for the early detection, diagnosis, and therapy of cancer. Through the integration of various imaging modalities such as mammography, ultrasound, MRI, CT, and tomosynthesis, MeVis enables the conversion of image data into manageable clinical information, contributing to improved patient outcomes and research results.
Main Products and Services
edit- MammoScape: MeVis's latest software solution developed for multimodal breast imaging. It offers efficient workflow optimization and improves diagnostic accuracy through the integration of multiple imaging techniques and the support of AI-Tools[2][3].
- Broad support of imaging modalities: MeVis offers software solutions for mammography, ultrasound, MRI, CT, and tomosynthesis to optimize breast diagnostics[4].
Mission and Values
editMeVis is committed to the mission of supporting the early detection and treatment of breast cancer through innovative software solutions. A central goal is to promote women's health and provide resources for the early detection and treatment of breast cancer[4].
Sustainability Goals and Initiatives
editMeVis is actively committed to promoting women's health and the fight against breast cancer. The company has been working for over 28 years to optimize breast cancer diagnostics and supports the development of innovative solutions to improve healthcare[4].
Overall, MeVis positions itself as a pioneer in image-based medicine by providing clinicians with tailored technologies to improve the diagnosis and treatment of cancer.